In this edition, Fagron Genomics is once again looking forward to sharing experiences, learning and connecting with all IMCAS participants at booth N153 (level 1) at the Palais des Congrès in Paris.
Its stand, formed by a team of professionals in genetics and personalized medicine, will attend to all those requests, queries and information that visitors wish to know about genomics, and above all with the aim of showing them how the study of patient DNA can help them make better informed decisions and consequently increase patient satisfaction.
Fagron Genomics is a manufacturer of in vitro diagnostic medical devices specializing in the development and servicing of medical genetic algorithms, aimed at offering personalized treatments to patients. Its commitment is to provide the highest quality clinical genetic interpretation and deliver accurate, clinically actionable results to help healthcare professionals make better and more informed decisions. Its manufacturing license for the development of In Vitro Diagnostics (IVD) Medical Device Software, is a guarantee of trust and commitment to quality and safety.
Fagron Genomics offers a 360° solution based on DNA analysis. Its service supports healthcare professionals throughout the entire process, from the DNA sample collection kit supply to personalized advice on patient treatment, ensuring a complete experience through appropriate clinical genetic counselling and training.
Fagron Genomics offers a wide range of advanced genetic tests in the fields of Dermatology, Aesthetics, Nutrition and Healthy Aging, and thanks to its constant innovation, will soon offer more tests aimed at other areas of medicine.
AcneTest: Pharmacogenetic test that improves the treatment of acne, providing an exhaustive understanding of the patient’s immune response and also their predisposition to various processes related to the pathophysiology of acne.
TrichoTest TM : Pharmacogenetic test that determines whether a male or female subject having androgenetic alopecia, alopecia areata, or telogen effluvium is likely to be responsive to the administration of specific hair loss treatments.
TeloTest: Innovative biomarker of biological age evaluating telomere-related diseases, providing the most appropriate formula recommendation to delay the effect of ageing.
FillerTest: Unique genetic test that shows whether a patient’s genetic predisposition may cause an increased risk of serious complications from fillers.
NutriGen: Innovative nutrigenomic algorithm for personalizing nutrition, supplementation and weight loss planning.
About Fagron Genomics, S.L.U. Fagron Genomics is based in Barcelona (Spain). Their authorized medical laboratory is ISO 15189 compliant. The company’s proprietary algorithms, are ISO 13485 compliant and integrated into a secure digital healthcare platform that meets the requisite regulatory and data protection standards.
For more information, visit fagrongenomics.com
